1.
Pharmacodynamic Studies and Preclinical Safety Evaluations of Dehydrocavidine;
脱氢卡维汀药效学研究及临床前安全性评价
2.
The Application Status of Genetically Modified Carcinogenesis Animal Model in Preclinical Safety Evaluation of Pharmaceuticals
遗传修饰致癌性动物模型与药物临床前安全性评价
3.
Hemostatic and Anticoagulatic Mechanism and Preclinical Safety Evaluation of Recombinant Batroxobin;
重组巴曲酶止血作用机制研究及临床前安全性评价
4.
Analysis on Expansion Potentials and Pre-clinical Safeties of Hematopoietic Stem Cells from Human Umbilical Cord Blood;
脐带血造血干/祖细胞体外扩增制剂及其临床前安全性检测分析
5.
Histology of the Zymbal's Gland in Different Aged SD Rats on Safety Evaluation of Preclinical Drugs
不同周龄SD大鼠外耳道腺结构与药物临床前安全性评价
6.
Discussion on the Pre-clinical Safety Evaluation of the Allergic Reactions in the Cephalosporin Antibiotics
头孢菌素类抗生素过敏反应临床前安全性评价的探讨
7.
Problems in preclinical safety evaluation of the new TCM external preparations for rheumatism,orthopedics and surgery
风湿、骨科、外科外用中药制剂临床前安全性评价中需关注的问题
8.
Study on the Outcome and Safty of Preimplantation Genetic Diagnosis
植入前遗传学诊断的临床结局和安全性
9.
Technical requirements from ICH for Preclinical Cardiac Safety Evaluation of Pharmaceuticals
ICH对药物临床前心脏安全性评价的技术要求
10.
Clinical safety data management of new durgs in the pre-approval phase
新药上市前临床试验安全性数据的管理
11.
Clinical safety data analysis and evaluation of new durgs in the pre-approval phase
新药上市前临床试验安全性数据的分析与评价
12.
Discussion on the size of clinical safety database of new durgs in the pre-approval phase
关于新药上市前临床安全性数据库规模的探讨
13.
Consideration on clinical safety database of new durgs in the pre-approval phase
新药上市前有关临床安全性数据库的考虑因素
14.
Preclinical testing for safety and efficacy: risk/benefit ratio assessment.
临床前的安全性及有效性测试应用：风险/获益比评估。
15.
Safety and Efficacy of Qianliean Suppository for Chronic Prostatitis of Damp-Heat and Blood-Stasis Syndrome:A Randomized,Single-Blind,Parallel Controlled,Multi-Centered Phase Ⅲ Clinical Trial
前列安栓治疗慢性前列腺炎(湿热瘀血壅阻证)的安全性和有效性的Ⅲ期临床试验
16.
Considerations for current evaluation for nonclinical safety of compound preparations from traditional Chinese medicine
对当前中药复方制剂非临床安全性评价的若干思考
17.
Standardization of tissue sampling and trimming from rats and mice in preclinical safety evaluation study
临床前药物安全性评价中大小鼠组织取材标准化的探讨
18.
The Role of Clinical Physicians in the Safety Evaluation of Traditional Chinese Medicine
临床医师在中药安全性评价中的作用